TSE:MFC

Manulife Financial (MFC.TO)

57.19
+0.15 (0.26%)
as of Jun 26, 2026, 8:00:00 pm Market Open.
1634 watching
0
Investor Insights
star iconJun 26, 2026, 12:00 am

This summary was created by AI, based on 28 opinions in the last 12 months.

Manulife Financial (MFC) has garnered mixed reviews from experts, reflecting a range of perspectives on its current standing and future potential. Several analysts highlight the company's strong dividend yield and its robust performance in Asia, suggesting it may be a worthwhile long-term investment, particularly for those seeking income rather than growth. However, concerns regarding earnings fluctuations, market pullbacks, and comparisons with peers like Sun Life Financial indicate that MFC may not be as attractive as other options in the life insurance sector. Many experts recognize the potential for capital appreciation, yet they caution that the stock faces headwinds, especially when considering broader market dynamics and the performance of similar financial institutions. There is a prevailing sentiment that the stock remains a reliable choice, albeit needing careful monitoring amidst potential market corrections.

consensus icon
Consensus
Hold
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
PAST TOP PICK
(A Top Pick July 23/09. Down 32.13%.) A fabulous value however, the track looks awful and until he sees some basing he wouldn't touch it.
WAIT
Would wait because it came so far down recently. If they take another loss like a year ago, it could take time for them to recover. From this level it could double or go to $10-$12. CEO made good moves to raise money with dividend cut etc. Is watching it and if it came down a bit he could go for it.
HOLD
Has a very large amount of equity exposure to get balance sheet back on side. Did a terrific job in raising capital so balance sheet is fairly strong and the company will be on side in 3-5 years. Would rather be in Canadian bank stocks at the moment and avoid insurers.
DON'T BUY
Not a Buy right now because it still has too much exposure to equity markets. Likes this as an insurance company, probably one of the best in the world. North American operations are very profitable. Likes their growth in the far east.
COMMENT
New CEO (2 years ago) that inherited a company that needed drastic changes. Cut dividends in half. Sell annuities that are tied to different stock markets so have a lot of exposure to capital markets globally. If you feel capital markets are going to come out stronger, this is a Buy. He looks at this as a trading opportunity.
COMMENT
Put up some decent numbers but the multiple keeps compressing. Viewed as a levered play on equity markets and there are concerns about more equity issues to keep ratios in line. For safety go to Royal Bank (RY-T) but for a leverage play on the market you can go to this one.
BUY
In the short-term, as the market goes down people worry about the guarantees on index portfolios. Stock is now trading below Book. Tremendous franchise with lots of international growth. If you are a long-term investor and can take the volatility it is a great buy at this price. If the market keeps going down, this will follow.
WAIT
Starting to look good but you are in better to be prudent than to jump in right now. He'd rather pay $3, $4, $5 higher and know there is no double dip. Still has clouds over it. (See To0p Picks.)
SELL
Chart shows a very distinctive downward trend with no indication that it wants to bottom. Tends to do very well from around the beginning of October to end of November and end of February to end of May. Better opportunities elsewhere.
TOP PICK
Market is not giving this company the credit it deserves. Have made significant progress over the last couple of years in shoring up their balance sheet. Operate in 22 countries. Much stronger capital base so their equity products are not at as much risk. Can see earnings coming back at the $2 level in the next few years.
HOLD
Face the dilemma of investing premiums. Over 3% dividend.
COMMENT
Great Asian business. Growth looks decent. Fixed the balance sheet but to do so, alienated a bunch of investors by cutting the dividend in half. Cheap valuation. Doesn't expect an increase in dividends until late next year.
HOLD
Trading at about 8.5X this year's earnings and 7.5X next year’s. 3% dividend yield. Still suffering from having to raise some much capital during the financial crisis of 2009. Also suffering from their tie to the market but it is long-term exposure so he is not concerned about it. Great operation in Asia.
PAST TOP PICK
(A Top Pick Dec 18/09. Down 10.56%.)
DON'T BUY
He has been Short this stock for the last little while. Have a great global franchise but the downside is the concerns that if the market where to get hit, this has a lot of market exposure. Quite a number of their segregated products come due in 2012.
Showing 1,456 to 1,470 of 2,281 entries